Seasonal Hyperacute Pan-Uveitis (SHAPU)

Seasonal Hyperacute Pan-Uveitis (SHAPU) is a very sudden and very strong inflammation inside the eye. “Pan-uveitis” means the inflammation involves the whole uveal tract of the eye—the front part (iris and ciliary body), the middle gel (vitreous), and the back part (choroid, retina). “Hyperacute” means it starts fast and worsens quickly—measured in hours to a few days, not weeks. “Seasonal” means it tends to appear in the same times of the year, often after the rainy season. In SHAPU, a child or sometimes a young adult develops a red eye, the white center of the pupil can look white from pus or debris (“white pupil”), vision can drop very quickly, and the entire eye can become inflamed in a short time. This condition has been reported almost entirely from Nepal for many decades, and it often affects children, usually in post-monsoon months; clusters have been noticed in some years more than others, which is why doctors call it “seasonal” and “cyclic.” The exact cause is still being studied, but many reports link SHAPU with exposure to white or tussock moths and their hairs (called setae) around the time symptoms begin. Doctors sometimes find tiny moth hairs in the eye, and some studies have found bacteria in eye samples, so experts think SHAPU may be a mixed trigger: tiny hairs can enter the eye and irritate it, and germs on the hairs or on the eye surface may add infection or trigger strong immune reactions. SHAPU is a medical emergency because the eye can lose vision very fast if not treated promptly. EyeWikiPMC+2PMC+2Lippincott Journals

Seasonal Hyperacute Pan-Uveitis—often shortened to SHAPU—is a very fast, very aggressive inflammation inside the eye. It has been reported almost exclusively in Nepal since 1975, mostly in children, and it usually affects only one eye. It tends to appear after the monsoon and through early winter; clusters have also been described in some even-years during summer. Without prompt specialist treatment, vision can be lost within days. Several studies link outbreaks to contact with white moths (particularly Gazalina spp.) or their microscopic hairs, although the exact cause is still being studied. Typical features are a “white pupil in a red eye,” minimal pain, low eye pressure, hypopyon, dense vitreous exudates, and an eye that can quickly become soft. SHAPU is an emergency. EyeWikiPMCLippincott JournalsNepJol

A classic clinical clue written in the literature is a “white pupil in a red eye” that appears quickly in an otherwise healthy child, often without a history of surgery or obvious trauma. Some children feel little pain; others complain of pain and light sensitivity. The pressure in the eye can be low, the front chamber can look shallow, and thick inflammatory material may collect at the bottom of the front chamber (a “hypopyon”). These are warning signs that need urgent eye care. EyeWiki

Researchers and public-health teams in Nepal have followed SHAPU for almost fifty years. They have reported repeating post-monsoon outbreaks, often in odd-numbered years, and occasional events outside that pattern. The strong, repeating seasonality and the observed links with moth exposure have turned SHAPU into a high-priority eye-health concern in Nepal. Even today, scientists are still working to map the moth species involved, test for microorganisms carried on the hairs, and understand why children are most affected. PMC+1Taylor & Francis OnlineNature

---

Types

Because the exact cause is not fully proven, doctors mainly “type” SHAPU by how it looks, who it affects, and how it starts. These types are descriptive and help plan tests and care:

1. Typical post-monsoon childhood SHAPU
   This is the most described form. It strikes soon after the monsoon, usually in children, and often in one eye (unilateral). It comes on very fast with a red eye, white pupil, and rapid loss of vision. Exposure to moths is often reported by family members. EyeWikiPMC

2. Sporadic or off-cycle SHAPU
   These cases appear outside the usual cycle (for example, an even-year or a different season). They look the same in the clinic but do not follow the common timing pattern, reminding doctors that the disease can occur any year even if most clusters follow a rhythm. PMC

3. Setae-documented SHAPU
   In some patients, doctors can see or detect moth hairs in the cornea or anterior segment using a microscope or anterior-segment OCT. This supports a mechanical/foreign-body trigger in that case. Lippincott Journals

4. Anterior-dominant vs posterior-dominant presentations
   All layers are inflamed in SHAPU, but some eyes show more front-of-eye findings (hypopyon, fibrin, small pupil) while others show stronger back-of-eye findings (vitritis, vasculitis, choroid/retina involvement). Doctors note this so they can choose the most useful imaging and tests. (General panuveitis patterns referenced.) PMC

5. Severe complicated SHAPU
   A subset progresses to complications such as dense vitritis, retinal involvement, or very low eye pressure in a short time. These eyes often need rapid imaging, samples, and urgent treatment. EyeWiki

---

Causes

Important note: Researchers agree the exact cause is not fully proven. The list below explains hypotheses, associated triggers, and risk modifiers discussed in the literature and clinical reports. Where evidence is strong (e.g., moth exposure), I state that clearly; where ideas are still being studied, I say “possible” or “proposed.”

1. Exposure to white/tussock moths (strong association)
   Many affected children report recent contact with or presence of white/tussock moths at home or outdoors. This link appears again and again in reports from Nepal. PMC+1Taylor & Francis Online

2. Penetration of moth hairs (setae) into the eye
   Tiny barbed hairs can stick to the eye surface and sometimes enter deeper tissues, causing ophthalmia nodosa—a known inflammatory reaction to insect hairs. In SHAPU, setae have been seen and imaged in some eyes. Lippincott JournalsEyeWiki

3. Bacterial contamination on setae or ocular surface
   Cultures in some series have found bacteria in eye samples, suggesting bacteria may ride in on hairs or enter a vulnerable eye and amplify inflammation. NepJol

4. Allergic or immune hypersensitivity to moth proteins (proposed)
   Some patients may have a strong immune reaction to proteins on the hairs or moth body, which can trigger pan-uveitis even if live infection is not dominant. (Mechanism inferred from ophthalmia nodosa literature.) EyeWiki

5. Seasonal moth population surges after monsoon
   After the rains, moth numbers may bloom, increasing contact chances, especially where houses use bright lights at night that attract moths. This helps explain the seasonal pattern. (Epidemiologic inference from SHAPU seasonality reports.) PMC+1

6. Children’s behavior and exposure
   Children play outdoors, touch insects, and rub their eyes more. This behavioral exposure likely raises risk, which matches the age pattern reported. PMC

7. Household lighting at dusk and night (possible risk)
   Outdoor bulbs and indoor lights near windows can attract moths toward children’s faces and eyes. Families in affected regions have described this setting in case reports. (Context from SHAPU reportage and field notes.) PMC

8. Sleeping near open windows without nets (possible risk)
   Open windows in post-monsoon weather can let moths into bedrooms where children sleep, increasing incidental eye contact. (Public-health inference consistent with SHAPU prevention advice.) ResearchGate

9. Rubbing eyes after touching moths
   Hands carry hairs to the eye. Even a light rub can push hairs deeper into the surface. (Mechanism extrapolated from ophthalmia nodosa behavior.) EyeWiki

10. Minor corneal micro-scratches
    Small, unnoticed scratches can make it easier for hairs and germs to enter and trigger inflammation. (General ocular-surface principle, applied to SHAPU context.) EyeWiki

11. Local bacterial biofilm from environmental dust (proposed)
    Post-monsoon dust and debris may carry bacteria that find the inflamed eye a favorable site. This could create a mixed inflammatory-infective picture in some cases. (Inference alongside reports of positive bacterial cultures.) NepJol

12. Specific moth species biology
    Different moth species have different setae structures and toxins. Historical work pointed at a tussock moth; later field studies have considered Gazalina species. Species biology may affect the severity of ocular reaction. Taylor & Francis Online

13. Cyclic environmental patterns
    Alternating climate conditions and host–insect life cycles may explain odd-year peaks and sporadic even-year events. (Epidemiologic observation; cause under study.) PMC

14. Delayed care after first symptoms
    SHAPU worsens rapidly. Delay can allow inflammation and any co-infection to spread. This is a risk for poor outcomes, if not a direct biologic cause. (Clinical logic consistent with rapid-progression reports.) EyeWiki

15. Barbed hair migration inside the eye
    Setae can move with eye movements or inflammation and carry surface bacteria to deeper tissues, escalating a local reaction into pan-uveitis. (Mechanism extrapolated from ophthalmia nodosa and SHAPU case imaging.) Lippincott JournalsEyeWiki

16. Immune system priming in children (proposed)
    Children may mount brisk innate responses to unusual proteins, tipping the balance toward a hyperacute inflammation. (Immunologic inference to explain pediatric predominance.) PMC

17. Concurrent viral or bacterial conjunctivitis (possible co-factor)
    A mild, common eye infection could weaken barriers and make setae-triggered reactions more severe. (General principle; specific SHAPU co-infection patterns are still being studied.) PMC

18. Community outbreaks and clustering
    When many households see moth swarms, multiple cases can occur in short windows, raising exposure risk and highlighting environmental drivers. The Lancet

19. Mechanical trauma from removing hairs
    Picking or wiping at an eye with stuck hairs may drive them deeper, worsening the response. (Practical inference consistent with setae mechanics.) EyeWiki

20. Unknown co-factors
    Scientists are still testing for microbes, toxins, and genetic factors that could amplify disease in certain seasons and places. Ongoing field work and sequencing aim to answer these gaps. Nature

---

Symptoms

1. Sudden red eye
   The white part of the eye turns red quickly because small blood vessels open up during inflammation.

2. Rapid drop in vision
   Sight can fall in hours to days because inflammation clouds the clear media and can involve the retina.

3. White pupil
   The pupil can look white because pus and dense debris collect behind it and reflect light, creating a “white pupil in a red eye”—a classic warning sign in SHAPU. EyeWiki

4. Light sensitivity (photophobia)
   Bright light hurts or worsens discomfort because the inflamed iris and ciliary body react to light.

5. Tearing or watering
   The eye waters as a reflex to irritation and inflammation.

6. Foreign-body sensation
   It may feel like something is in the eye because tiny hairs or inflamed tissue rub the inner surface.

7. Eye ache or pressure sensation
   Some children report aching pain or a full feeling; others may have surprisingly little pain even with severe inflammation. Acta Scientific

8. Small, stuck pupil
   Inflammation can make the pupil small and poorly responsive due to fibrin and sticky inflammatory proteins.

9. Floaters
   Dark spots drift in the vision because inflammatory cells float in the vitreous gel.

10. Hazy vision
    Cloudy cornea, anterior chamber “cells/flare,” and vitreous haze all scatter light and blur images.

11. Headache
    Irritation around the eye can radiate to the forehead and temple.

12. Lid swelling
    The eyelids can puff up from local inflammation.

13. Mild fever or unwell feeling (sometimes)
    Some children feel mildly unwell, but many are otherwise healthy—another reason SHAPU can be missed at first.

14. Low eye pressure sensations
    The eye can feel “soft” if pressure drops due to ciliary shutdown from inflammation; this is usually noticed by the doctor, not the child. EyeWiki

15. Very fast worsening
    The overall picture can worsen in a day or two, which is why SHAPU is a true emergency. EyeWiki

---

Diagnostic tests

Doctors use tests to confirm inflammation, look for triggers, and rule out mimics. Because SHAPU is hyperacute and vision-threatening, clinicians move quickly and choose tests with the highest yield.

A) Physical Examination

1. Slit-lamp biomicroscopy
   A microscope exam of the front of the eye checks for cells/flare, fibrin, hypopyon, keratic precipitates, and any visible setae embedded in the surface. This exam gives the first, most important clues in SHAPU. NCBI

2. Intraocular pressure (IOP) measurement
   Tonometry measures eye pressure. In SHAPU, the eye may be soft due to ciliary body shutdown. A very low pressure is an alarm sign. EyeWiki

3. Dilated fundus examination
   With drops that enlarge the pupil, the doctor looks at the vitreous, retina, vessels, and optic nerve for vitritis, vasculitis, or choroidal/retinal lesions—key findings in pan-uveitis. PMC

4. External/periocular inspection with fluorescein surface staining
   The doctor examines eyelids, conjunctiva, and cornea and may apply fluorescein dye to reveal scratches and track marks, which might hint at setae entry points. (General uveitis exam practice.) NCBI

B) Manual/Bedside Functional Tests

5. Visual acuity (Snellen) and pinhole test
   Simple charts measure baseline sight. A pinhole helps distinguish blur from refractive error versus media inflammation. NCBI

6. Pupillary light reflex and swinging-flashlight test
   Checks for a relative afferent pupillary defect (RAPD) that can signal retinal or optic-nerve involvement in severe cases. (Core neuro-ophthalmic screen.) NCBI

7. Color vision (Ishihara) or red-desaturation test
   Detects macular/optic pathway dysfunction that might not show on acuity alone; helpful once media clears enough to test. (General uveitis assessment practice.) NCBI

8. Confrontation visual fields
   A quick bedside map of central and peripheral vision to spot dense scotomas from posterior inflammation. (General clinic practice.) NCBI

C) Laboratory & Pathology

9. Complete blood count (CBC), ESR, and CRP
   These basic labs look for inflammation or infection signals and help guide urgency and broader work-up. (General uveitis work-up guidance.) American Academy of Ophthalmology

10. Aqueous or vitreous culture and Gram stain
    If infection is suspected, tiny samples from the eye are sent for bacterial and fungal cultures. In SHAPU, some series have found bacteria, supporting a possible infective component in certain eyes. NepJol

11. Polymerase chain reaction (PCR) on ocular fluid
    PCR can detect DNA from viruses (HSV, VZV, CMV) and bacteria when cultures are slow or negative. This helps separate sterile inflammation from infection. ScienceDirect

12. Syphilis and tuberculosis testing (serology and IGRA/TST)
    Because these infections can mimic or complicate uveitis, many experts include RPR/TPPA (or FTA-ABS) and TB tests in the first-line work-up when the picture is severe. PMCScienceDirect

13. Sarcoid and spondyloarthropathy markers (ACE/lysozyme, chest imaging; HLA-B27 when indicated)
    These tests target important systemic causes of uveitis. They do not diagnose SHAPU, but they help rule out mimics in a very inflamed eye. ScienceDirect

14. Cytology or microscopy for setae
    When a hair is seen or removed, microscopy can confirm an insect seta. In one report, anterior-segment OCT helped identify setae embedded in cornea. Confirmation supports the SHAPU mechanism in that case. Lippincott Journals

D) Electrodiagnostic Tests

15. Electroretinogram (ERG)
    ERG measures the retina’s electrical response to light. In dense media haze or later follow-up, ERG helps assess retinal function beyond what the view allows. It is not a first test in emergencies but adds value in severe posterior disease. PMCNature

16. Visual evoked potential (VEP)
    VEP measures signals from the optic nerve to the brain. It helps if vision is very poor and the team needs to know how much of the pathway remains functional. (Adjunctive, not first-line.) PMC

E) Imaging Tests

17. Optical coherence tomography (OCT) of macula and optic nerve
    OCT gives cross-section “slices” through the retina and optic nerve head. It shows macular edema, subretinal fluid, or choroidal thickening, which are common targets of treatment in uveitis. It also helps monitor response over time. PMC

18. B-scan ocular ultrasound
    When the view is blocked by vitritis or corneal haze, ultrasound checks for retinal detachment, choroidal thickening, or masses. It is fast and bedside-friendly in hyperacute eyes. (General uveitis imaging practice.) Mayo Clinic

19. Fluorescein angiography (FA) / Indocyanine green angiography (ICGA)
    These dye tests map retinal and choroidal circulation. FA can reveal retinal vasculitis and leakage; ICGA highlights choroidal changes. In uveitis, FA is a gold-standard tool for retinal vessel inflammation, while ICGA complements the choroid. ScienceDirectSpringerOpen

20. Anterior-segment OCT (AS-OCT) and OCT-Angiography (OCT-A)
    AS-OCT can show embedded setae, corneal tracks, and inflammatory membranes in the front of the eye—helpful in SHAPU. OCT-A gives a dye-free view of retinal and choroidal blood-flow patterns and can support posterior-segment assessment when FA is deferred. Lippincott JournalsPMC

Non-pharmacological treatments (therapies & others)

(Each item includes a short description, purpose, and “how it helps.”)

1. Urgent referral to an eye hospital
   Description: Rapid triage and transfer to a center that can perform diagnostic taps, intravitreal therapy, and vitrectomy.
   Purpose: Beat the disease’s speed.
   Mechanism: Shortens time to sight-saving procedures (tap/vitrectomy/injections) shown in published protocols for SHAPU. EyeWikiLippincott Journals

2. Protective eye shield (not a pressure patch)
   Description: A rigid shield over the eye.
   Purpose: Stops accidental rubbing and new hairs or debris entering the eye.
   Mechanism: Mechanical protection while the inflamed eye is fragile and soft.

3. Light control and dark sunglasses
   Description: Keep the environment dim and use wrap-around sunglasses.
   Purpose: Reduce photophobia and strain.
   Mechanism: Less sensory irritation gives comfort and helps the exam.

4. Head elevation during rest
   Description: Sleep with the head raised.
   Purpose: Improve comfort and reduce dependent pooling of inflammatory material.
   Mechanism: Gravity assists fluid settling without pressure on the eye.

5. Strict “no rubbing, no pressure” rule
   Description: Hands off the eye; avoid tight garments and compressive masks.
   Purpose: Prevents micro-trauma and further anterior chamber reaction.
   Mechanism: Stops more hair fragments (setae) from penetrating and avoids IOP drops.

6. Careful removal of visible insect hairs in clinic
   Description: Under slit-lamp, a clinician may try to tease out corneal/cameral hairs when safe.
   Purpose: Reduce a persistent trigger.
   Mechanism: Directly removes an irritant that has been documented in SHAPU corneas. Lippincott Journals

7. Sterile ocular surface irrigation (in clinic)
   Description: Judicious lavage of the conjunctival sac by professionals.
   Purpose: Decrease superficial debris and inflammatory load.
   Mechanism: Mechanical removal under aseptic conditions.

8. Diagnostic aqueous and vitreous tap
   Description: Sampling eye fluids for culture/PCR, often immediately before intravitreal therapy.
   Purpose: Identify or rule out pathogens; guide therapy.
   Mechanism: Confirms whether an infection is present and helps tailor antibiotics. EyeWiki

9. B-scan ultrasonography (when fundus view is blocked)
   Description: Bedside ocular ultrasound.
   Purpose: Decide if there is retinal detachment or dense vitreous exudate.
   Mechanism: Imaging “through the haze” to plan surgery. Lippincott Journals

10. Hospital monitoring with standardized protocols
    Description: Vital signs, IOP checks, serial slit-lamp/ultrasound documentation.
    Purpose: Track change hour by hour.
    Mechanism: Timely escalation (repeat intravitreal, earlier vitrectomy). EyeWiki

11. Infection control and asepsis
    Description: OR-level sterility for taps/injections.
    Purpose: Prevent iatrogenic infection.
    Mechanism: Standard endophthalmitis precautions.

12. Pain and comfort strategies without pressure
    Description: Cool room, lubricants if advised, gentle eyelid hygiene.
    Purpose: Symptom relief while avoiding unsafe home remedies.
    Mechanism: Comfort without masking worsening signs.

13. Avoidance of over-the-counter topical anesthetics at home
    Description: Do not use numbing drops outside clinical settings.
    Purpose: They delay healing and hide danger signs.
    Mechanism: Prevents corneal toxicity.

14. Early counseling for the family
    Description: Honest discussion about urgency, possible outcomes, and need for follow-up.
    Purpose: Improves adherence to fast-moving care plans.
    Mechanism: Shared understanding lowers delays that worsen prognosis. Lippincott Journals

15. Low-vision services (if vision loss occurs)
    Description: Magnifiers, contrast tools, orientation & mobility.
    Purpose: Optimize remaining vision early.
    Mechanism: Neuro-adaptation and training improve daily function.

16. Environmental control at home during season
    Description: Limit white/bright outdoor lights that attract moths; use screens, nets.
    Purpose: Reduce ongoing exposure in the days after presentation.
    Mechanism: Source control while the eye heals. Lippincott Journals

17. Careful hand/face washing after any insect contact
    Description: Soap and water promptly; change contaminated clothing.
    Purpose: Remove irritant hairs and toxins.
    Mechanism: Physical decontamination; emphasized in case reports. Lippincott Journals

18. School/community alerting in affected areas
    Description: Notify local health/education leads.
    Purpose: Spot more cases early and spread prevention messages.
    Mechanism: Public-health awareness; outbreaks recur seasonally. PMC

19. Psychological support
    Description: Brief counseling, child-friendly explanations.
    Purpose: Reduce fear and improve cooperation with care.
    Mechanism: Better tolerance of exams/procedures.

20. Documented follow-up schedule
    Description: Written plan with clear “return now if…” warnings.
    Purpose: Catch re-flares or complications quickly.
    Mechanism: Structured surveillance fits SHAPU’s hyperacute course. EyeWiki

---

Drug treatments

These are physician-administered/prescribed. Doses below reflect published SHAPU protocols and common uveitis/endophthalmitis practice—not do-it-yourself advice.

1. Topical moxifloxacin 0.5% (fluoroquinolone) – hourly
   Purpose: Broad antibacterial cover while work-up proceeds.
   Mechanism: Inhibits bacterial DNA gyrase/topoisomerase.
   Side effects: Stinging, rare allergy. EyeWiki

2. Topical prednisolone acetate 1% – hourly (then taper)
   Purpose: Control the explosive intraocular inflammation.
   Mechanism: Glucocorticoid suppression of cytokines and leukocyte trafficking.
   Side effects: ↑IOP, cataract risk with prolonged use. EyeWiki

3. Atropine 1% (cycloplegic) – 2–3×/day
   Purpose: Rest the iris/ciliary body, prevent synechiae, ease pain.
   Mechanism: Muscarinic blockade → dilation & cycloplegia.
   Side effects: Light sensitivity, blurred near vision. EyeWiki

4. Intravenous ceftriaxone (children 50–75 mg/kg/day; adults 1–2 g q24h or q12h)
   Purpose: Systemic gram-negative/gram-positive cover when infection isn’t excluded.
   Mechanism: Beta-lactam inhibition of cell-wall synthesis.
   Side effects: GI upset, rare biliary sludging. EyeWiki

5. Intravenous methylprednisolone “pulse” (weight-based for 1–3 days), then oral prednisone (1–2 mg/kg/day) with taper
   Purpose: Rapidly quench severe inflammation once infection is being managed.
   Mechanism: Broad immunosuppression.
   Side effects: Hyperglycemia, mood change, infection risk—requires close monitoring. EyeWiki

6. Intravitreal vancomycin (1.0 mg/0.1 mL)
   Purpose: Direct intraocular gram-positive cover.
   Mechanism: Inhibits bacterial cell-wall synthesis.
   Side effects: Rare retinal toxicity; requires OR-level sterility. EyeWiki

7. Intravitreal amikacin (0.4 mg/0.1 mL) or ceftazidime (2.25 mg/0.1 mL)
   Purpose: Direct gram-negative cover (either aminoglycoside or cephalosporin).
   Mechanism: Protein synthesis inhibition (amikacin) or cell-wall inhibition (ceftazidime).
   Side effects: Rare macular toxicity (notably with aminoglycosides), so dosing is precise. EyeWikiPMCActa Scientific

8. Intravitreal dexamethasone (0.4 mg/0.1 mL)
   Purpose: Calm intravitreal inflammation when combined with antibiotics.
   Mechanism: Local steroid effect with high intraocular levels.
   Side effects: IOP rise—monitored by the care team. EyeWiki

9. Topical antibiotic prophylaxis (e.g., moxifloxacin continued q1–2h, then taper)
   Purpose: Maintain surface cover post-procedures.
   Mechanism: Prevent secondary infection. EyeWiki

10. Alternative cycloplegic (e.g., homatropine) as needed
    Purpose/Mechanism/Side effects: As with atropine; selection depends on response and availability. EyeWiki

Why so aggressive? Early antibiotics + steroids + early surgery are used because many eyes otherwise progress to phthisis. Outcomes improve when the clock to vitrectomy/intravitreal therapy is short. PubMedLippincott Journals

---

Dietary “molecular” supplements

There is no supplement that treats SHAPU. In acute SHAPU, procedures and medicines above come first. These nutrients are general anti-inflammatory or ocular-supportive adjuncts your clinician may or may not consider once the eye is stabilized.

1. Omega-3 DHA/EPA – 1–2 g/day combined EPA+DHA.
   Function: Anti-inflammatory lipid mediators (resolvins). Mechanism: Competes with arachidonic acid pathways.

2. Vitamin D3 – typically 1,000–2,000 IU/day (dose guided by blood levels).
   Function: Immune modulation. Mechanism: Nuclear receptor signaling dampens Th1/Th17 activity.

3. Vitamin C – 500–1,000 mg/day.
   Function: Antioxidant; supports collagen and wound healing.

4. Zinc – 10–20 mg elemental/day short-term.
   Function: Enzyme cofactor; supports epithelial repair.

5. Lutein + Zeaxanthin – 10 mg + 2 mg/day.
   Function: Macular antioxidant pigments; general retinal support.

6. Curcumin (enhanced bioavailability form) – 500–1,000 mg/day with piperine or phospholipid formulation.
   Function: NF-κB pathway modulation; anti-inflammatory.

7. Quercetin – 500 mg/day.
   Function: Flavonoid antioxidant; mast-cell stabilization.

8. N-acetylcysteine (NAC) – 600–1,200 mg/day.
   Function: Glutathione precursor; reduces oxidative stress.

9. Probiotics (multi-strain) – as labeled.
   Function: Gut–immune axis support; may modestly tune systemic inflammation.

10. Resveratrol – 150–300 mg/day.
    Function: Polyphenol with antioxidant signaling effects.

These do not replace medical treatment and should be cleared with an ophthalmologist—especially if you’re on steroids or immunomodulators.

---

Advanced” immunomodulatory / regenerative therapies

Important context: These agents are approved or studied for non-infectious uveitis, not specifically for SHAPU. In SHAPU’s hyperacute phase, clinicians prioritize intravitreal antibiotics, steroids, and early vitrectomy. The options below may be discussed later if infection is excluded and inflammation proves refractory. Evidence is from broader uveitis literature.

1. Adalimumab (anti-TNF-α) – 40 mg subcut every 2 weeks (adult dosing; pediatric dosing is weight-based).
   Function/Mechanism: Blocks TNF-α to reduce ocular inflammation.
   Evidence: Randomized phase 3 VISUAL I trial showed lower relapse/visual-impairment risk in active noninfectious uveitis vs placebo. Not studied for SHAPU specifically. PubMedPMC

2. Infliximab (anti-TNF-α, IV) – 5–10 mg/kg at weeks 0, 2, 6 then q8 weeks.
   Function: Similar to adalimumab; used off-label in severe uveitis.
   Evidence: Observational series support benefit in refractory cases (noninfectious uveitis). Not SHAPU-specific.

3. Methotrexate (antimetabolite) – typically 10–25 mg once weekly + folic acid.
   Function: Steroid-sparing immunomodulation.
   Evidence: Controls ocular inflammation in many patients; widely used in uveitis clinics. PMCclinexprheumatol.org

4. Mycophenolate mofetil (MMF) – usually 1–2 g/day in divided doses.
   Function: Lymphocyte proliferation inhibitor; steroid-sparing.
   Evidence: Cohort studies show good control in noninfectious uveitis. PubMedNature

5. Cyclosporine A (calcineurin inhibitor) – ~3–5 mg/kg/day (clinician-titrated).
   Function: T-cell activation blockade; used in select uveitis patients.

6. Mesenchymal stem cell–based therapies (investigational)
   Function: Immunomodulation and pro-repair signaling (incl. exosomes).
   Evidence: Preclinical animal models show reduced ocular inflammation; human use remains experimental and not standard of care for SHAPU. PMCPubMedBioMed Central

---

Surgeries & procedures

1. Early core pars plana vitrectomy (within ~24 hours where feasible)
   What: Remove inflamed vitreous, obtain diagnostic sample, and deliver intravitreal drugs.
   Why: Improves drug penetration, lowers inflammatory/toxin load, and can improve outcomes in protocols used for SHAPU. EyeWikiPubMed

2. Diagnostic vitreous/aqueous tap (often combined with vitrectomy)
   What: Small fluid samples for Gram/KOH, cultures, PCR.
   Why: To confirm/rule out infection and tailor therapy. EyeWiki

3. Intravitreal injections (antibiotics ± steroid)
   What: Vancomycin + amikacin/ceftazidime ± dexamethasone at the end of surgery; repeat in 48 h if needed.
   Why: Delivers high drug levels inside the eye where the disease is most active. EyeWiki

4. Lensectomy as part of vitrectomy (selected cases)
   What: Remove the lens if it obstructs access/view or is involved.
   Why: Enhance clearance of exudates and permit safer posterior segment work. ScienceDirect

5. Therapeutic corneal procedures for melt/perforation (rare SHAPU cases)
   What: Tissue adhesive and bandage contact lens, therapeutic keratoplasty if needed.
   Why: Restore integrity when corneal melting/perforation occurs. (Corneal melt has been reported in SHAPU clusters; keratoplasty is a standard rescue for large perforations in general corneal disease.) PMCEyeWiki

---

Prevention

1. Avoid direct contact with white moths, especially those with black stripes and tufted tails. PMC

2. Reduce bright/white outdoor lighting during peak season; switch to less attractive spectra and keep windows screened. Lippincott Journals

3. Keep children indoors at dusk when moth swarms are noted; supervise play near lit walls/curtains. PMC

4. Do not rub the eyes after any moth exposure; wash face and hands with soap and water. Lippincott Journals

5. Shake out curtains, bedding, and clothes near lights; clean surfaces where moths rest. Lippincott Journals

6. Use bed nets/screens in endemic regions during the season. EyeWiki

7. Wear wrap-around glasses when sweeping areas with moths. EyeWiki

8. Teach schools and families to recognize “white pupil in a red eye” and seek immediate care. EyeWiki

9. Report clusters to local health services for community alerts. Lippincott Journals

10. If one case is identified in a community, proactively share prevention messages to neighbors. Lippincott Journals

---

When to see a doctor

• Right away (same day) if a child—or anyone—has sudden unilateral red eye with a white pupil, vision drop, minimal pain, or an unusually soft eye after the monsoon season.

• Right away if there has been recent moth exposure and eye redness follows. These are classic clues clinicians use to flag SHAPU and start emergency care. EyeWiki

---

What to eat and what to avoid

What to eat ( ideas):

1. Water and adequate fluids—in hospital, IV fluids may be used if needed.

2. Leafy greens (spinach, kale) for lutein/zeaxanthin.

3. Oily fish (sardine, mackerel) for omega-3s.

4. Citrus/berries for vitamin C.

5. Eggs (yolks contain lutein/zeaxanthin).

6. Nuts/seeds (almonds, flax, chia) for healthy fats.

7. Lean proteins (supports healing).

8. Colorful vegetables (polyphenols).

9. Probiotic-rich foods (yogurt, kefir) if tolerated.

10. Whole grains/legumes for steady energy.

What to avoid ( ideas):

1. Self-medicating with herbal eye drops or anesthetic drops.

2. Rubbing or pressing the eye; avoid tight eye patches.

3. Smoking and second-hand smoke.

4. Highly salty ultra-processed foods (worsen fluid balance).

5. Excess sugar spikes.

6. Unregulated supplements promising “cures.”

7. Alcohol excess, especially while on steroids/antibiotics.

8. Exposure to moth-attracting lights during recovery.

9. Dusty sweeping without eye protection in endemic areas.

10. Skipping follow-ups or stopping prescribed medicines early.

---

FAQs

1. Is SHAPU an infection or an allergy?
   We don’t fully know. Many cases look like a toxin or hair-induced inflammation, sometimes with organisms found on testing. Most centers treat both possibilities (antibiotics + steroids) and operate early. EyeWiki

2. Why is a white moth mentioned so often?
   Epidemiology links outbreaks to white moth exposure; hairs have been found within the cornea in some patients. The Gazalina moth group is strongly suspected. Lippincott JournalsNepJol

3. Why does it happen after monsoon?
   That’s when moth numbers surge; seasonal patterns and even sporadic summer outbreaks have been documented. PMC

4. Does it always hurt?
   Often not much—that’s part of the danger. The eye can be very inflamed but only mildly painful, so families may come late. EyeWiki

5. What’s the hallmark sign?
   A white pupillary reflex in a red eye with rapid vision loss and low eye pressure. EyeWiki

6. What is the first thing hospitals do?
   Assess vision/IOP, perform diagnostic taps, start topical/systemic antibiotics and steroids as indicated, and often move quickly to vitrectomy with intravitreal drugs. EyeWiki

7. Will my child need surgery?
   Often yes—early vitrectomy is common and may be repeated if needed. EyeWiki

8. Can SHAPU lead to blindness even with treatment?
   Unfortunately, yes—historical series show many eyes ending in phthisis without prompt care; outcomes are better when treatment is started fast. PubMed

9. Are there tests to find the exact bug?
   Clinicians send aqueous/vitreous for Gram/KOH, culture, and sometimes PCR. Results guide antibiotics, though many cases are culture-negative. EyeWiki

10. Should we use eye patches or home rinses?
    Use a shield, not a pressure patch. Home rinses can be risky; cleansing should be done in clinic. EyeWiki

11. Do vitamins cure SHAPU?
    No. Nutrition supports health but does not replace medical/surgical treatment. (Supplements listed above are optional adjuncts.)

12. Are biologic drugs or stem cells used?
    Biologics (like adalimumab) help noninfectious uveitis; not standard for SHAPU. Stem-cell approaches are experimental in animal models. PubMedPMC

13. Can SHAPU spread from one person to another?
    It is not considered person-to-person contagious; outbreaks are linked to environmental exposure. PMC

14. What can communities do during season?
    Reduce white lights, use screens/nets, teach the warning sign, and set up fast referral pathways. Lippincott JournalsEyeWiki

15. What if the white moth mystery stays unsolved?
    Care still improves when families and clinicians act early with established protocols. Research continues (including entomology and virology). Taylor & Francis Online

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: August 24, 2025.